A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/165 (2006.01) A61K 31/197 (2006.01) A61P 21/00 (2006.01) A61P 25/00 (2006.01) A61P 29/00 (2006.01)
Patent
CA 2467356
The present invention provides a method of treating, in a mammal, chronic fatigue syndrome (CFS), chronic fatigue syndrome (CFS) that is associated with depression, a combination of chronic fatigue syndrome (CFS) and fibromyalgia syndrome (FMS), fibromyalgia syndrome (FMS) associated with depression, pain and pain associated with depression. The method includes administering a therapeutically effective amount of a dual serotonin norepinepbrine reuptake inhibitor compound or a pharmaceutically acceptable salt thereof.
la présente invention concerne une méthode de traitement, chez un mammifère, de l'encéphalo-myélite myalgique, de l'encéphalo-myélite myalgique associée à la dépression, d'une combinaison d'encéphalo-myélite myalgique et du syndrome de la fibromyosite, du syndrome de la fibromyosite associé à la dépression, de la douleur et de la douleur associée à la dépression. La méthode consiste à administrer une dose thérapeutiquement efficace d'un composé inhibiteur double de recaptage de la sérotonine et de la norépinéphrine ou un sel de ce composé acceptable au plan pharmaceutique.
Kranzler Jay D.
Rao Srinivas G.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Cypress Bioscience Inc.
LandOfFree
Selective norepinephrine serotonin reuptake inhibitors for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selective norepinephrine serotonin reuptake inhibitors for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective norepinephrine serotonin reuptake inhibitors for... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1496304